NEW YORK, Feb. 19, 2018 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Credit Suisse Group AG (NYSE:CS) from March 20, 2015 through February 3, 2016, inclusive (the “Class Period”) of the important February 20, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Credit Suisse investors under the federal securities laws.
To join the Credit Suisse class action, go to http://rosenlegal.com/cases-1260.html or call Phillip Kim, Esq. or Daniel Sadeh, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, during the Class Period defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Credit Suisse’s risk protocols and control systems were routinely disregarded; (2) Credit Suisse was amassing billions of dollars of risky, highly illiquid securities, in violation of those risk protocols; and (3) as a result, defendants’ statements about Credit Suisse’s business, operations, and risk controls were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 20, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1260.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Daniel Sadeh, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Daniel Sadeh, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com


ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 



